BRCA1 mutation carriers develop breast and ovarian cancer at a younger age than BRCA2 mutation carriers, and BRCA2 is associated with fewer cases of breast cancer than BRCA1 [15]. This evidence concerns the gene BRCA1 and breast carcinoma.